Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) EBT Margin (2016 - 2025)

Historic EBT Margin for Perspective Therapeutics (CATX) over the last 16 years, with Q3 2025 value amounting to 18034.03%.

  • Perspective Therapeutics' EBT Margin fell 129933600.0% to 18034.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 13081.34%, marking a year-over-year decrease of 145272200.0%. This contributed to the annual value of 5787.77% for FY2024, which is 23596600.0% down from last year.
  • Latest data reveals that Perspective Therapeutics reported EBT Margin of 18034.03% as of Q3 2025, which was down 129933600.0% from 12864.91% recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' EBT Margin ranged from a high of 343.25% in Q4 2023 and a low of 18034.03% during Q3 2025
  • Its 5-year average for EBT Margin is 3689.64%, with a median of 500.45% in 2023.
  • Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 1018000bps in 2021, then crashed by -144197900bps in 2024.
  • Perspective Therapeutics' EBT Margin (Quarter) stood at 56.96% in 2021, then crashed by -316bps to 236.92% in 2022, then skyrocketed by 245bps to 343.25% in 2023, then tumbled by -4201bps to 14076.55% in 2024, then decreased by -28bps to 18034.03% in 2025.
  • Its EBT Margin was 18034.03% in Q3 2025, compared to 12864.91% in Q2 2025 and 8493.93% in Q1 2025.